+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase receptor expression among peripheral blood cells and leukemic cell lines

Urokinase receptor expression among peripheral blood cells and leukemic cell lines

Tissue Antigens 42(4): 363

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 034144183

Download citation: RISBibTeXText

Related references

Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells. Thrombosis and Haemostasis 76(6): 1009-1019, 1996

In situ quantitation of PAI2 expression and monocytic differentiation Determination in leukemic cell lines and in normal or leukemic peripheral blood cells. Analytical Cellular Pathology 6(3): 266, 1994

Regulation of prolactin expression in leukemic cell lines and peripheral blood mononuclear cells. Journal of Neuroimmunology 135(1-2): 107-116, 2003

Assessment of G-CSF and GM-CSF mRNA expression in peripheral blood mononuclear cells from patients with severe congenital neutropenia and in human myeloid leukemic cell lines. Experimental Hematology 21(1): 163-168, 1993

Expression of cannabinoid receptor 1 and 2 by human malignant cell lines and peripheral blood stem cells. FASEB Journal 15(4): A25, March 7, 2001

Glyco proteins of peripheral blood cells and in the urine of leukemic patients comparison with the glyco protein pattern of cell lines derived from leukemic children by affinity labeling with concanavalin a. Journal of Clinical Chemistry & Clinical Biochemistry 20(3): 128, 1982

Different expression of the interleukin-17 receptor mRNA in T cell lines and peripheral blood lymphocytes cultured with and without contact with CD13+ stromal cells. European Journal of Cell Biology 75(SUPPL 48): 85, 1998

Cell surface expression of urokinase receptor in normal mammary epithelial cells and breast cancer cell lines. Anticancer Research 19(2a): 1223-1228, 1999

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis. Thrombosis and Haemostasis 84(4): 680-688, 2000

Expression of a non-T, non-B ALL associated antigen on leukemic cells, lymphoblastoid cell lines and normal blood cells. Blut 40(5): 305-312, 1980

Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. Journal of Immunology 159(10): 4720-4728, 1997

Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines. Journal of Clinical Investigation 77(6): 1740-1746, 1986

Expression of gelatinase A and B in cord blood CD34+ cells and leukemic cell lines. Zhonghua Xue Ye Xue Za Zhi 24(2): 78-81, 2003

G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia. Annals of Clinical and Laboratory Science 38(4): 331-337, 2008

Differential regulation of urokinase-type-1 inhibitor complex endocytosis by phorbol esters in different cell lines is associated with differential regulation of alpha 2-macroglobulin receptor and urokinase receptor expression. Molecular and Cellular Endocrinology 109(2): 209-217, 1995